Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer

R I Nicholson1, R A McClelland, J F Robertson

  • 1Tenovus Cancer Research Centre, University of Wales College of Medicine, Cardiff, UK.

Endocrine-Related Cancer
|October 12, 1999
PubMed

Insights

Steroid hormone and growth factor interactions influence breast cancer endocrine response. Understanding these pathways is key for improving breast cancer treatment and overcoming endocrine resistance.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Steroid hormone and growth factor signaling pathways are crucial in breast cancer development and progression.
  • Aberrations in these pathways contribute to endocrine resistance, a major challenge in breast cancer treatment.

Purpose of the Study:

  • To investigate the cross-talk between steroid hormone and growth factor signaling in breast cancer.
  • To understand the role of these interactions in endocrine response and resistance.

Main Methods:

  • The study likely involved analyzing molecular signaling pathways in breast cancer cells or tissues.
  • Methods may include techniques like gene expression analysis, protein interaction studies, and functional assays.

Main Results:

  • Evidence suggests that the interplay between steroid hormones and growth factors modulates endocrine response in breast cancer.
  • Disruptions in growth factor signaling are frequently observed in endocrine-resistant breast cancer phenotypes.

Conclusions:

  • Delineating the relationships between steroid hormone and growth factor signaling is a critical diagnostic objective in cancer research.
  • Targeting aberrant growth factor signaling pathways presents a promising strategy to enhance therapeutic efficacy and overcome endocrine resistance in breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...